GLP-1-Analoga zur Diabetes-Behandlung
Dulaglutide Study - Penn Medicine
Molecular mechanisms redirecting the GLP-1 receptor signalling profile in pancreatic β-cells during type 2 diabetes
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors | The Review of Diabetic Studies
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes - IRBM
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
PharmaWiki - GLP-1-Rezeptor-Agonisten
How Does GLP-1 Affect Diabetes?
GLP-1 ist mehr als ein Antidiabetikum | SpringerLink
Downregulation of the GLP-1/CREB/adiponectin pathway is partially responsible for diabetes-induced dysregulated vascular tone and VSMC dysfunction - ScienceDirect
![glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "glp-1_analogs [TUSOM | Pharmwiki]")
glp-1_analogs [TUSOM | Pharmwiki]
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
![PDF] GLP-1 Based Combination Therapy for Obesity and Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/73983626886b6439761b6844997806367e881df8/3-Figure1-1.png "PDF] GLP-1 Based Combination Therapy for Obesity and Diabetes | Semantic Scholar")
PDF] GLP-1 Based Combination Therapy for Obesity and Diabetes | Semantic Scholar
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology
Medikamente gegen Typ-2-Diabetes: GLP-1-Analoga | Apotheken Umschau
PharmaWiki - GLP-1-Rezeptor-Agonisten
Therapeutic potential of GLP-1 in type 2 diabetes mellitus | Download Table
Nonpeptidic glucagon-like peptide 1 receptor agonists: A magic bullet for diabetes? | PNAS
Diabetes-Kurs - Tablettentherapie: Weniger Risiken durch die richtige Auswahl
GLP-1-Analoga: Second Line nach Metformin? - Endokrinologie & Diabetologie - Universimed - Medizin im Fokus
Emerging Role of Dual GLP-1 and GIP Receptor Agonists | DMSO
Was GLP-1-Analoga und DPP-4-Hemmer versprechen - Endokrinologie & Diabetologie - Universimed - Medizin im Fokus
